Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$401.80 USD
+9.56 (2.44%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $401.59 -0.21 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALNY 401.80 +9.56(2.44%)
Will ALNY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALNY
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Other News for ALNY
UBS Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $550 | ALNY Stock News
Alnylam (ALNY) Target Price Raised by Truist Following Strong Q2 Results
Alnylam (ALNY) Target Price Boosted by Scotiabank Amid Amvuttra Momentum
Alnylam Pharmaceuticals (ALNY) Receives Raised Price Target from Canaccord Genuity | ALNY Stock News
Wells Fargo Raises Alnylam Pharmaceuticals (ALNY) Price Target to $395 | ALNY Stock News